Cottone G, Laterza G, Amici A, Gentile V, Perugia G, Russo G, Scibinetti F, Ronchi F, Zappi P, Clemenzia G
Minerva Med. 1986 Oct 6;77(38):1717-20.
The behaviour of N-acetyl-B-D-Glucosaminidase (NAG) was studied in the urine of patients with chronic pyelonephritis under pharmacological treatment for renewed attacks of acute renal inflammation. It was noted that by the end of target chemo-antibiotic treatment all patients presented a reduction in the inflammation and hence the tubular distress. Once treatment was suspended several patients showed an increase tendency in the activity of the enzyme followed by the reappearance of significant bacteriuria and/or leukocyturia. The acute attack of renal inflammation would not have been recognised if the enzymuria technique had been used to monitor the patients.
对慢性肾盂肾炎患者在接受药物治疗以应对急性肾炎症复发期间的尿液中N - 乙酰 - β - D - 氨基葡萄糖苷酶(NAG)的行为进行了研究。注意到在目标化疗 - 抗生素治疗结束时,所有患者的炎症均减轻,从而肾小管损伤也减轻。一旦治疗暂停,几名患者的酶活性呈现增加趋势,随后出现明显的菌尿和/或白细胞尿。如果使用酶尿技术监测这些患者,急性肾炎症发作可能不会被识别。